Diffuse Bio Analysis
What is Diffuse Bio?
Diffuse Bio develops generative AI for protein design, enabling the engineering of new proteins with exceptional control and precision.
Employees
10
Founded
2022
Revenue
$1.5M
Business Model
Subscription and project-based agreements for AI-driven platforms and services.
Company Stage
Seed
Investors
- Y Combinator
- GreatPoint Ventures
- Fellows Fund
YC Batch
W23
Product Features & Capabilities
- generative AI for protein design, Diffuse StructGen-1 (DSG-1) for designing nanobody binders, achieving a hit rate of 3%, capable of designing strong binders in the <=10nM range, computational design of therapeutics, vaccines, and enzymes, overcoming limitations of existing computational protein des
Competitors Overview
Diffuse Bio operates in the generative AI for protein design market, which has several notable competitors. Here are some of the main competitors:
- DeepMind: Known for its AlphaFold technology, DeepMind has made significant advancements in protein folding predictions. Its AI models can predic
Market Focus
Diffuse Bio primarily focuses on the biotechnology industry, specifically in the area of protein design and engineering using generative AI technology.
See something that needs updating? Suggest edits to this profile.